Cargando…
DNA damage and metabolic mechanisms of cancer drug resistance
Cancer drug resistance is one of the main barriers to overcome to ensure durable treatment responses. While many pivotal advances have been made in first combination therapies, then targeted therapies, and now broadening out to immunomodulatory drugs or metabolic targeting compounds, drug resistance...
Autores principales: | Tiek, Deanna, Cheng, Shi-Yuan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
OAE Publishing Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9255237/ https://www.ncbi.nlm.nih.gov/pubmed/35800362 http://dx.doi.org/10.20517/cdr.2021.148 |
Ejemplares similares
-
The Many Facets of Therapy Resistance and Tumor Recurrence in Glioblastoma
por: Goenka, Anshika, et al.
Publicado: (2021) -
Stem cell programs in cancer initiation, progression, and therapy resistance
por: Huang, Tianzhi, et al.
Publicado: (2020) -
The Role of Non-Coding RNAs in Glioma
por: Goenka, Anshika, et al.
Publicado: (2022) -
Targeting the DNA Damage Response to Overcome Cancer Drug Resistance in Glioblastoma
por: Ferri, Alessandra, et al.
Publicado: (2020) -
Temozolomide-induced guanine mutations create exploitable vulnerabilities of guanine-rich DNA and RNA regions in drug-resistant gliomas
por: Tiek, Deanna M., et al.
Publicado: (2022)